Arnold Magnetic Technologies Highlights Custom Electromagnetic Capabilities for Medical Applications

Arnold Magnetic Technologies Corporation (Arnold), a subsidiary of Compass Diversified (NYSE: CODI) and leading global manufacturer of high-performance magnets and precision thin metals, highlights its custom electromagnetics used in medical applications. By providing critical components for oncology equipment, Arnold’s electromagnets (also known as solenoids) save lives and provide the flexibility needed in generating magnetic fields so necessary for critical waveguide applications.

Arnold manufactures a wide variety of custom electromagnets that generate uniform or proportioned magnetic field shapes and with a wide range of magnetic field intensities. These electromagnets are either made up of tape wound foil wafers or built up from coils of wire.

All Arnold tape wound electromagnets feature coils that are electrically controlled to the precise field strength desired. Depending upon specific requirements, magnetic field distribution may be uniform, or it may have peaks, plateaus, and valleys along the axial length of the electromagnet, Shaped field electromagnets can be custom-designed to specific configurations with great precision. Coils may be of various widths within the electromagnet and they can be made interchangeable.

Customers can select nominal ID and OD to meet application size requirements. Also available are special designs that use chilled oil or liquid nitrogen to allow higher than normal current, generating up to 200 percent greater field intensity than an uncooled design.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”